undamentalytics Newsletter
Sign in

Amarin Corp plc\uk income statement

In fiscal 2025, Amarin Corp plc\uk reported revenue of $214m, down 6.5% on the year before, operating income of −$50.2m (a -23.5% margin) and net income of −$38.8m, or −$1.80 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue265482130181229430614583369307229214176
Cost of revenue———34455596131121—————
Gross profit143454961361753344834622421668112172
Research and development7350515047563439293022212019
Selling, general and administrative1247910111113522732446340830420015211578
Operating income−182−96−98−66−46−108−24−2011−106−68−92−50−32
Interest expense341920191097300000—
Income before tax−169−59−118−76−55−116−22−1711−104−54−77−36−17
Income tax−3−3−31013001425532
Net income−166−56−115−86−68−116−23−188−106−59−82−39−19
Diluted EPS—−$7.20—−$8.20−$5.00−$7.80−$1.40−$1.00$0.40−$5.20−$3.00−$4.00−$1.80−$0.91
Diluted shares (average)8m9m9m11m14m15m17m19m20m20m20m21m21m21m
EBITDA−182−96−98−65−45−108−24−1911−105−67−92——

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AMRN vs CRONAMRN vs KMDAAMRN vs BTMDAMRN vs HRTX

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Amarin Corp plc\uk's SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Amarin Corp plc\uk.